img
Welcome to Biotechgate, your AI-guided life sciences intelligence platform.
Company Profile Preview
Company logo

Moderna, Inc.

Headquarters
Cambridge, USA
See full record
Company
Therapeutics
Technologies
Clinical trials
License agreements
Financing rounds
Management
Partnering Interests
Financials
Reports & Forecasts

Main Sector

Biotechnology - Therapeutics and Diagnostics

Subsectors

Antibodies
Anti-infectives
Drug delivery
Nucleic acid drugs
Proteins
Vaccines
Immunotherapy

Indications

Infectious and parasitic diseases / infectiology / parasitology
Neoplasms / cancer / oncology
Diseases of the blood and blood-forming organs & immune disorders / hematology / immunology
Endocrine, nutritional and metabolic diseases / endocrinology
Diseases of the nervous system / neurology
Cardiovascular / cardiology
Respiratory / pulmonology
Digestive system / gastroenterology
Congenital malformations, deformations and chromosomal abnormalities / medical genetics
Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

Products

In development: 40
On the market: 15

Description

Moderna, Inc. is a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines. The company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range spectrum of diseases. The company's product SPIKEVAX is a vaccine indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory...

 

Log in to see full record »

No account yet?

Try Biotechgate now - learn about subscription plans and pricing!
Learn more Request a demo
© 2026 Venture Valuation
Terms of Use & Privacy Policy